معرفی
Christofer Juhlin is an Associate Professor of Experimental Pathology at Karolinska Institutet and Deputy Senior Consultant in Surgical Pathology at Karolinska University Hospital. He leads the Molecular Endocrine Pathology research group investigating genetic mechanisms in endocrine tumors (thyroid, parathyroid, adrenal). His clinical focus is endocrine pathology diagnostics.
Education:
- Docent, Karolinska Institutet (2016)
- PhD, Karolinska Institutet (2009)
- Medical Degree, Karolinska Institutet (2008)
- BSc Molecular Biology, Stockholm University
His research explores molecular drivers of endocrine tumors using genomics and immunohistochemistry to improve diagnostics/prognostics. Key interests include telomerase regulation (TERT), microRNA processing defects (DICER1/DGCR8), and biomarker development for thyroid/adrenal malignancies. Recent work emphasizes spatial transcriptomics and radiopharmaceutical therapeutics.
Publications (2022-2025) predominantly focus on: 1) Molecular classification of thyroid/neuroendocrine tumors, 2) TERT/DICER1 mutation impacts, 3) Novel biomarkers for aggressive phenotypes, and 4) Therapeutic target discovery in anaplastic thyroid cancer.
Awards & Grants:
- Junior Clinical Investigator Award (Swedish Cancer Society)
- M.D. Ph.D Scholarship (Karolinska Institutet)
- Fernström Foundation Scholarship
- Current funding: Swedish Cancer Society, Swedish Medical Society, Cancer Society of Stockholm
He leads a translational research team developing diagnostic algorithms and novel therapies for endocrine cancers. The group collaborates internationally on WHO classification systems and maintains biobanks for molecular studies.
